United Therapeutics Beats HHS' Discount-Dodging Claims
A federal judge in Washington, D.C., has ruled that the federal government can't go after United Therapeutics and Novartis over their marketing policies limiting the number of drugs sold as part of...To view the full article, register now.
Already a subscriber? Click here to view full article